(HealthDay)—Psoriasis is associated with an increased risk for thyroid disease among U.S. adults, according to research published online March 16 in the Journal of the American Academy of Dermatology. Jeffrey Liu, from the Keck School of Medicine at the University…
Read More
What Drives Treatment Satisfaction Among Adults With AD?
Atopic dermatitis (AD) is associated with lower patient satisfaction scores in adults, suggesting there are unmet needs in clinical AD management. Satisfaction scores were higher when specialists prescribed systemic therapy, but were lower when nonspecialists prescribed systemic therapy and when…
Read More
Our Journeys With Chronic Illness Aren't Meant to Be Solo
Life with an invisible illness presents many challenges. For me, one of the biggest challenges is an extreme sense of isolation. At 19, I was diagnosed with psoriatic arthritis. At a time when people assumed I was vibrant, full of…
Read More
Celestone M
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CELESTONE® M Betamethasone valerate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Celestone M. It does not contain all the…
Read More
APO-Sotalol
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-SOTALOL TABLETS Sotalol hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about sotalol. It does not contain all the available…
Read More
Study identifies more genes that are likely behind psoriasis and eczema
A Swedish study has identified 17 new genes that could be targeted for treatment of psoriasis and eczema, two common hereditary skin diseases with no cure. Pelin Sahlén, senior lecturer at KTH Royal Institute of Technology, says that the combined…
Read More
Shift seen to newer agents to treat psoriasis
(HealthDay)—Phototherapy use for psoriasis decreased from 2005 to 2018, while use of biologics increased, according to a research letter published online Sept. 4 in Dermatologic Therapy. Mytrang H. Do, Ph.D., from Weill Cornell Medicine in New York City, and colleagues…
Read More